TIAM2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.210300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.577700E-02
Normal-vs-Stage2
4.542500E-02
Normal-vs-Stage3
2.797800E-01
Normal-vs-Stage4
4.872600E-01
Stage1-vs-Stage2
2.230200E-01
Stage1-vs-Stage3
6.660000E-01
Stage1-vs-Stage4
5.871600E-02
Stage2-vs-Stage3
6.909800E-01
Stage2-vs-Stage4
3.007000E-01
Stage3-vs-Stage4
3.796400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.816100E-02
Normal-vs-AfricanAmerican
3.619600E-01
Normal-vs-Asian
4.891900E-02
Caucasian-vs-AfricanAmerican
5.479400E-01
Caucasian-vs-Asian
3.499800E-01
AfricanAmerican-vs-Asian
2.942800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.147600E-02
Normal-vs-Female
4.500500E-02
Male-vs-Female
8.675000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.301200E-01
Normal-vs-Age(41-60Yrs)
1.480980E-01
Normal-vs-Age(61-80Yrs)
3.162200E-02
Normal-vs-Age(81-100Yrs)
4.094400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.516600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.104800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.655000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.783800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.077400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.937800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.858030E-01
Normal-vs-Daily Drinker
2.329600E-01
Normal-vs-Weekly Drinker
3.102200E-02
Normal-vs-Occasional Drinker
3.754800E-01
Normal-vs-Social Drinker
4.483700E-02
Non Drinker-vs-Daily Drinker
5.397900E-02
Non Drinker-vs-Weekly Drinker
3.454200E-01
Non Drinker-vs-Occasional Drinker
5.946800E-01
Non Drinker-vs-Social Drinker
4.693800E-01
Daily Drinker-vs-Weekly Drinker
4.311400E-01
Daily Drinker-vs-Occasional Drinker
5.441800E-02
Daily Drinker-vs-Social Drinker
2.632000E-01
Weekly Drinker-vs-Occasional Drinker
1.716210E-01
Weekly Drinker-vs-Social Drinker
7.704800E-01
Occasional Drinker-vs-Social Drinker
2.485600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.057980E-01
Normal-vs-Grade 2
2.269500E-02
Normal-vs-Grade 3
6.054000E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.448400E-01
Grade 1-vs-Grade 3
7.055900E-02
Grade 1-vs-Grade 4
1.057980E-01
Grade 2-vs-Grade 3
1.817820E-01
Grade 2-vs-Grade 4
2.269500E-02
Grade 3-vs-Grade 4
6.054000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.912170E-02
Normal-vs-NonDiabetic
8.536400E-02
Diabetic-vs-NonDiabetic
3.350800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.360000E-01
Normal-vs-NoPancreatitis
7.591600E-02
Pancreatitis-vs-NoPancreatitis
2.755800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.206350E-01
Normal-vs-N1
5.692200E-02
N0-vs-N1
7.213200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.742000E-01
Normal-vs-TP53-NonMutant
6.266300E-02
TP53-Mutant-vs-TP53-NonMutant
5.260200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
